Clinical Trial Update: ZEUS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Cardiovascular Disease, Chronic Kidney Disease and Inflammation [Phase 3]

View source ↗

Summary

Phase 3 trial update for ZEUS evaluating ziltivekimab versus placebo in individuals with cardiovascular risk, chronic kidney disease, and inflammation; study co…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease
• Chronic Kidney Disease

Drugs mentioned

• Ziltivekimab

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Cardiovascular Risk, Chronic Kidney Disease | Phase 3 | Status: COMPLETED